Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function

Circulation

Volumn 96, Issue 9, 1997, Pages 2892-2898

  Dakik, Habib Abbas ^a   Howell, Jimmy F ^a   Lawrie, Gerald M ^a   Espada, Rafael ^a   Weilbaecher, Donald G ^a   He, Zuo Xiang ^a   Mahmarian, John J ^a   Verani, Mario S ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Bypass; Coronary disease; Myocardial contraction; Perfusion; Scintigraphy

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HISTOPATHOLOGY; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SCINTIGRAPHY;

EID: 0030711682     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.9.2892     Document Type: Article

References (31)

1. Elefteriades J, Tolis G Jr, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22:1411-1417.
2. Bonow RO, Dilsizian V. Thallium-201 for assessment of myocardial viability. Semin Nucl Med. 1991;21:230-241.
3. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314: 884-888.
4. Schelbert H. Metabolic imaging to assess myocardial viability. J Nucl Med. 1994;35(suppl):8S-14S.
5. Bonow RO, Berman DS, Gibbons RJ, Johnson LL, Rumberger JA, Schwaiger M, Wackers FJ. Cardiac positron emission tomography: a report for health professionals from the Committee on Advanced Cardiac Imaging and Technology of the Council on Clinical Cardiology, American Heart Association. Circulation. 1991;84:447-454.
6. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87: 1630-1641.
7. Iskandrian AS, Hakki AH, Kane SA, Goel IP, Mundth ED, Hakki AH, Segal BL. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol. 1983;51: 1312-1316.
8. Berger BC, Watson DD, Burwell LR, Crosby IK, Wellons HA, Teates CD, Beller GA. Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery. Circulation. 1979;60:1114-1125.
9. Kiat H, Berman DS, Maddahi J, De Yang L, Van Train K, Rozanski A, Friedman J. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol. 1988;12:1456-1463.
10. Yang LD, Berman DS, Kiat H, Resser KJ, Friedman JD, Rozanski A, Maddahi J. The frequency of late reversibility in SPECT thallium-201 stress-redistribution studies. J Am Coll Cardiol. 1990; 15:334-340.
11. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990;323:141-146.
12. 18F-fluorodeoxyglucose. Circulation. 1991;83:26-37.
13. Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM, Bonow RO. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium: comparison with metabolic activity by positron emission tomography. Circulation. 1993;88:941-952.
14. 99mTc sestamibi. Circulation. 1994;89: 2552-2561.
15. 18F]fluorodeoxyglucose. Circulation. 1994;89:578-587.
16. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol. 1996;27:1592-1597.
17. Verani MS, Gaeta J, LeBlanc AD, Poliner LR, Phillips L, Lacy JL, Thornby JI, Roberts R. Validation of left ventricular volume measurements by radionuclide angiography. J Nucl Med. 1985;26: 1394-1401.
18. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B, Bolli R. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol. 1988;12:1573-1581.
19. 99mTc-sestamibi in patients undergoing cardiac transplantation: a scintigraphic/pathologic study. Circulation. 1996; 94:1010-1017.
20. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med. 1992;33:1925-1930.
21. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m methoxyisobutyl isonitrile. J Nucl Med. 1992;33:505-511.
22. Sinusas AJ, Watson DD, Cannon JM Jr, Beller GA. Effect of ischemia and post ischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol. 1989;14:1785-1793.
23. Beanlands RS, Dawood F, Wen WH, McLaughlin PR, Butany J, D'Amato G, Liu PP. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation. 1990;82:1802-1814.
24. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation. 1988;77:491-498.
25. 201Tl activity in irreversible defects as a marker of myocardial viability: clinicopathological study. Circulation. 1995;91:1016-1021.
26. Maes AF, Borgers M, Flameng W, Nuyts JL, van de Werf F, Ausma JJ, Sergeant P, Mortelmans LA. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT: correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol. 1997; 29:62-68.
27. Sawada SG, Allman KC, Musik O, Beanlands RS, Wolfe ER Jr, Gross M, Fig L, Schwaiger M. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol. 1994;23:92-98.
28. Soufer R, Dey HM, Ng CK, Zaret BL. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol. 1995;75:1214-1219.
29. He ZX, Verani MS, Liu XJ. Nitrate-augmented myocardial imaging for assessment of myocardial viability. J Nucl Cardiol. 1995;2:352-357.
30. 201Tl reinjection enhances detection of reversible myocardial hypoperfusion: a randomized, double-blind, parallel placebo-controlled trial. Circulation. 1997;95:1799-1805.
31. Vanoverschelde JLJ, Wijns W, Borgers M, Heyndrickx G, Depré C, Flameng W, Melin JA. Chronic myocardial hibernation in humans: from bedside to bench. Circulation. 1997;95:1961-1971.